[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ETNOWlive Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::225012752.png) ET NOW [@ETNOWlive](/creator/twitter/ETNOWlive) on x 871.2K followers
Created: 2025-06-20 02:47:22 UTC

#BrokerageRadar | Nuvama on Aurobindo Pharma; Buy, target price ₹1,460 (cut from ₹1,485); Medium-term triggers intact, gRevlimid dip offset by US and EU launches

@Nuvama_Wealth

![](https://pbs.twimg.com/media/Gt2rn8HXUAAfNh0.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1935892200950509774/c:line.svg)

**Related Topics**
[dip](/topic/dip)
[aurobindo pharma](/topic/aurobindo-pharma)
[$auropharmans](/topic/$auropharmans)

[Post Link](https://x.com/ETNOWlive/status/1935892200950509774)